From: Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment
Characteristic
LAM plus ADV
(N = 25)
LAM
(N = 28)
P value
Male sex -no. (%)
20(80%)
21(75%)
0.664
Age - yr*
35.48
36.81
0.176
ALT - IU/L*
149.52
136.25
0.247
HBV DNA - log10 copies/ml*
5.89
5.96
0.812
Previous LAM therapy- yr*
3.60
3.88
0.115